Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$555M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$435M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$428M |
| 4 |
Accenture
ACN
|
+$402M |
| 5 |
Fortive
FTV
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$535M |
| 2 |
NVIDIA
NVDA
|
+$518M |
| 3 |
Coca-Cola
KO
|
+$488M |
| 4 |
AT&T
T
|
+$474M |
| 5 |
Meta Platforms (Facebook)
META
|
+$461M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.74% |
| 2 | Healthcare | 2.42% |
| 3 | Financials | 2.31% |
| 4 | Consumer Discretionary | 1.76% |
| 5 | Industrials | 1.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6326
Revolution Medicines
RVMD
$42.9B
| $1.7M | ﹤0.01% |
66,802
-297,103
| -82% | -$6.47M |
|
6327
PUT
Alliance Resource Partners
ARLP
$3.21B
| $1.7M | ﹤0.01% |
110,400
-108,400
| -50% | -$1.53M |
|
6328
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.41B
| $1.7M | ﹤0.01% |
17,342
+5,536
| +47% | +$540K |
|
6329
CALL
Credicorp
BAP
$30.4B
| $1.7M | ﹤0.01% |
9,900
-1,400
| -12% | -$211K |
|
6330
Roundhill Ball Metaverse ETF
METV
$213M
| $1.7M | ﹤0.01% |
142,341
-49,116
| -26% | -$612K |
|
|
SJR
6331
DELISTED
Shaw Communications Inc.
SJR
| $1.7M | ﹤0.01% |
54,826
+5,522
| +11% | +$166K |
|
6332
CALL
BioXcel Therapeutics
BTAI
$32.1M
| $1.7M | ﹤0.01% |
5,081
-1,638
| -24% | -$475K |
|
6333
Fluence Energy
FLNC
$2.45B
| $1.7M | ﹤0.01% |
129,654
+99,810
| +334% | +$1.67M |
|
|
SBOW
6334
DELISTED
SilverBow Resources, Inc.
SBOW
| $1.7M | ﹤0.01% |
+53,074
| New | +$1.36M |
|
|
HTBK
6335
DELISTED
Heritage Commerce
HTBK
| $1.7M | ﹤0.01% |
150,843
+37,008
| +33% | +$444K |
|
6336
Amkor Technology
AMKR
$14.5B
| $1.7M | ﹤0.01% |
78,043
-36,408
| -32% | -$824K |
|
6337
PUT
MBIA
MBI
$259M
| $1.69M | ﹤0.01% |
110,100
+37,800
| +52% | +$557K |
|
|
WW
6338
CALL
DELISTED
WW International
WW
| $1.69M | ﹤0.01% |
165,600
-88,700
| -35% | -$1.04M |
|
6339
PUT
CNX Resources
CNX
$5.23B
| $1.69M | ﹤0.01% |
81,700
-156,400
| -66% | -$2.6M |
|
6340
CALL
Popular Inc
BPOP
$11.3B
| $1.69M | ﹤0.01% |
20,700
+6,200
| +43% | +$548K |
|
6341
ProShares Ultra High Yield
UJB
$19M
| $1.69M | ﹤0.01% |
23,712
+18,086
| +321% | +$1.32M |
|
6342
PC Connection
CNXN
$2.04B
| $1.69M | ﹤0.01% |
32,271
-14,358
| -31% | -$679K |
|
6343
PUT
iShares Core S&P Mid-Cap ETF
IJH
$128B
| $1.69M | ﹤0.01% |
31,500
-500
| -2% | -$26.6K |
|
6344
CALL
NBT Bancorp
NBTB
$2.78B
| $1.69M | ﹤0.01% |
46,800
+32,100
| +218% | +$1.25M |
|
|
GBT
6345
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.69M | ﹤0.01% |
48,800
-25,200
| -34% | -$753K |
|
6346
Genuine Parts
GPC
$18.6B
| $1.69M | ﹤0.01% |
13,398
-57,697
| -81% | -$7.46M |
|
|
LYLT
6347
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
| $1.69M | ﹤0.01% |
102,125
+67,132
| +192% | +$1.67M |
|
6348
PUT
Arqit Quantum
ARQQ
$423M
| $1.69M | ﹤0.01% |
4,332
-5,288
| -55% | -$2.13M |
|
6349
Seres Therapeutics
MCRB
$46.9M
| $1.69M | ﹤0.01% |
11,849
-7,938
| -40% | -$1.22M |
|
6350
CALL
Brink's
BCO
$4.68B
| $1.69M | ﹤0.01% |
24,800
+6,300
| +34% | +$431K |
|
Similar funds
Citadel Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.
- Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
- Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
- Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
- Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
- Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
- Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.